Single-shot TAP Block vs Continuous TAP Block
Completed · Phase 4 · Has a placebo group
Conditions studied: Postoperative Pain
In brief
The purpose of this study is to determine whether continuous transversus abdominis plane (TAP) block is superior to single shot TAP for postoperative pain after laparoscopic donor nephrectomy
Key facts
- Study ID
- NCT02475031
- Run by
- Indiana University
- People needed
- 70
- Starts
- 2012-07-01
- Expected to finish
- 2015-12-01
- Last updated by the study team
- 2020-08-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Healthy subject undergoing laparoscopic live donor nephrectomy
- (ASA) American Society of Anesthesiologists class 1 or 2
- Age 18 or older, male or female
- Desires TAP block for postoperative pain control
You may not qualify if…
- Any contraindication for TAP block - single or continuous
- History of substance abuse
- Any physical, mental or medical conditions which, in the opinion of the investigators, may confound quantifying postoperative pain resulting from surgery.
- Known allergy or other contraindications to the study medications (Ropivacaine, Normal Saline, Hydromorphone, Oxycodone and Acetaminophen)
Where it is running
- Indiana University Hospital — Indianapolis, Indiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.